N ormal brain function requires the rapid transmission of information between brain regions along neuronal projections called axons. The ability of axons to conduct information depends on the well-being of a supporting class of glial cells called oligodendrocytes 1 , which speed up conduction by enveloping the axonal projections in a multi layered membrane sheath called myelin. Damage to oligodendrocytes and the myelin sheaths that they produce has been associated with axonal dysfunction in numerous disorders, including cerebral palsy, spinal-cord injury, multiple sclerosis and stroke. In this issue, Hamilton et al.
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, which speed up conduction by enveloping the axonal projections in a multi layered membrane sheath called myelin. Damage to oligodendrocytes and the myelin sheaths that they produce has been associated with axonal dysfunction in numerous disorders, including cerebral palsy, spinal-cord injury, multiple sclerosis and stroke. In this issue, Hamilton et al. 2 (page 523) report that the mechanisms that underlie this damage are more complex than commonly thought and involve the activation of a channel protein called TRPA1.
During a stroke, the local loss of blood flow in the brain, known as ischaemia, causes damage to neurons and glial cells, including oligodendrocytes. Even transient ischaemia causes permanent defects in axonal conductivity that can be only partially restored when the supply of oxygen and glucose to the tissue is re-established 3 . Ischaemia causes the release of the neurotransmitter molecule glutamate, which excites oligodendrocytes. Some evidence [3] [4] [5] indicates that blocking glutamatereceptor proteins reduces myelin damage and axon dysfunction during ischaemia. AMPA/ kainate-type and NMDA-type glutamate receptors are ion-channel proteins that, when activated, allow positively charged ions such as sodium (Na + ) and calcium (Ca 2+ ) to flow into the cell. High levels of Ca 2+ are toxic to cells, and so the death of oligodendrocytes and injury to myelin sheaths during ischaemia are widely thought to reflect the overactivation of these glutamate receptors [5] [6] [7] -the same mechanism by which ischaemia damages neurons.
Hamilton et al. revisited this issue in brain slices from the rat cerebellum. They found evidence that, in the cerebellar white matter (a tissue that contains a high density of myelinated axons) deprivation of oxygen and glucose -a model of ischaemia-evoked oligodendrocyte and myelin damage -might not result in glutamate-receptor overactivation alone. First, the authors characterized ischaemia-evoked membrane currents in oligodendrocytes and monitored the corresponding intracellular changes in Ca influx. After taking into account the known physiological properties of different ion-channel proteins and testing the effects of channel stimulators and inhibitors, the authors concluded that the channel responsible is TRPA1 -a widely expressed member of the family of transient receptor potential (TRP) channels (Fig. 1) . Activation of TRPA1 channels allows Ca 2+ , Mg 2+ and Na + to enter the cell. In line with Hamilton and colleagues' conclusion, ischaemia-triggered Ca 2+ entry was considerably reduced in white-matter cerebellum slices from mice in which TRPA1 had been deleted. However, the authors did not test the in vivo effects of ischaemia on white matter in these mice. Instead, using isolated optic nerves
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A mechanism for myelin injury
The cells that insulate neuronal processes with a myelin membrane sheath are damaged during stroke. Data now show that an influx of calcium ions mediated by the TRPA1 protein contributes to myelin injury. See Letter p.523 account for the ubiquitous multiple stellar populations in globular clusters, assuming that the observed massive young star clusters in the Magellanic Clouds are the modern counterparts of the old globular clusters. It is a plausible working hypothesis, but not a consensus view: some astronomers think that the formation mechanism of young massive star clusters in our neighbouring galaxies might be different from the globular-cluster formation that occurred in the early Universe. The link between young and old clusters has yet to be fully established. The determination of whether the chemical properties of the youngest stars in the Magellanic clusters are similar to those of globular-cluster stars will eventually address the issue.
Li and colleagues may not yet have all the answers needed to put the proposed general model on a firm quantitative footing. For example, the mass in the younger observed population sequence is much smaller than that typically observed in globular clusters. There is no explanation given for the origin of the additional helium that is claimed to be present in the youngest stars, nor for the fact that the accreted material must have the same metal content as the original protocluster, even though the host galaxies might have evolved chemically between the distinct star-formation events. (By 'metal' , astronomers mean any element after helium in the periodic Hamilton and colleagues' study demonstrates that in vitro damage to myelin owing to oxygen and glucose deprivation is more complex than anticipated, with TRPA1 channels joining the scene. Whether the results apply in vivo or to human TRPA1 channels, which have a different pharmacological response from those of mice 10 , remains to be seen. Trials of NMDAreceptor blockers in people who have had a stroke have largely failed, in part because the drugs were administered too late, given the low doses at which their adverse side effects can be tolerated. Identifying other pharmacological targets raises the hope that safer drugs may be found. ■ This article was published online on 13 January 2016.
from rats, the authors showed that blocking TRPA1 channels during oxygen and glucose deprivation reduced myelin damage, but had no effect on axonal injury. Thus, unlike the case with oligodendrocytes, damage to axons is mediated not by the activation of TRPA1 channels, but by other mechanisms of Ca 2+ influx. Hamilton et al. also detected spontaneous Ca 2+ -level changes in the myelin of some normal oligodendrocytes, which were not deprived of glucose and oxygen. This spontaneous activity is probably indicative of axonal activity and the concurrent release of glutamate. So, given that myelin contains AMPA/kainate and NMDA receptors [5] [6] [7] , and that ischaemia-evoked Ca 2+ -level changes in optic nerves have previously been shown to be caused by activation of glutamate receptors 5 , why did the authors not find evidence for glutamate-evoked Ca 2+ changes? The levels of the messenger RNAs that encode NMDA receptors are low in mature oligodendrocytes, but the levels of TRPA1 mRNA are almost undetectable 8 , and the researchers still detected TRPA1-mediated Ca 2+ influx in cerebellar oligodendrocytes. Evidence indicates that NMDA receptors move to myelin processes that face the axonal surface as oligodendrocytes mature 5, 6 . This might help to explain why glutamate-evoked Ca 2+ responses are difficult to detect in oligodendrocytes. Alternatively, perhaps oligodendrocytes in the optic nerve, which myelinate axons of only glutamate-releasing neurons, are different from the cerebellar oligodendrocytes that also myelinate neurons producing a different neurotransmitter, GABA.
In contrast to the current paper, a study published last month 9 provided evidence that, ). High levels of Ca 2+ are toxic to oligodendrocytes and damage myelin. Glutamate-receptor proteins such as NMDA-type receptors can also mediate Ca 2+ influx, but whether they have a role in ischaemia-evoked myelin damage in this setting is unclear.
BIOANALYTICAL DEVICES
Technological leap for sweat sensing
Sweat analysis is an ideal method for continuously tracking a person's physiological state, but developing devices for this is difficult. A wearable sweat monitor that measures several biomarkers is a breakthrough. See Letter p.509
J A S O N H E I K E N F E L D
A thletics trainers, physicians and even local pharmacists can take a sample of blood, saliva or urine and measure a whole panel of analytes (dissolved compounds) to reveal your physiological status at the time of sample collection. But none of the measurement techniques involved is conveniently portable or can continuously collect data for many hours or days -with the exception of glucose monitoring, which typically requires blood samples to be drawn by needle at regular intervals. On page 509 of this issue, Gao et al. 1 report a truly non-invasive, continuous biomonitoring device: a wearable, Bluetooth-enabled band containing a panel of sensors for sodium, potassium, lactate, glucose and skin temperature. And rather than using the body fluids mentioned above, the device measures analytes in human sweat.
Making a wearable band that electrochemically senses sweat analytes is extremely difficult. The sensors must be prepared from
